Intellipharmaceutics International Inc. (IPCI)

[AngeloFoca]

Factoring is the sale of receivables, whereas invoice discounting ("assignment of accounts receivable" in American accounting) is a borrowing that involves the use of the accounts receivable assets as collateral for the loan.

https://en.wikipedia.org/wiki/Factoring_(finance)

My feeling is the best solution here is to factor $10 million of the Focalin XR Royalty payments - and I believe that PAR would be a very interested party at 20% to 30% discount.

Assume $10 million factored at 70% to 80% - they could/would raise $7 to $8 million - and without even announcing it... assuming it's legal - take $5 million of that $7 or $8 million and buy 4 million IPCI shares on the open market - set it aside to later sell through the ATM at ~ $4 to $5 a share, and use the remaining $2 or $3 million to bring Rexista forward and secure a healthy partnership there.

The $10 to $12 million raised by the stock flipping transaction would more than make up for the 20% to 30% give away to the factoring.

The most practical thing right now is for IPCI to find a means to buy back stock in the open market at these ridiculously low prices.

Perhaps even offer the warrant holders 20 cents per warrant on the 1.5 million $1.90 warrants and disable that guillottine.